Literature DB >> 174420

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer.

E R Fisher, R Gregorio, C Redmond, A Dekker, B Fisher.   

Abstract

The morphologic appearances of regional lymph nodes in radical mastectomy specimens obtained from 303 women entered into a prospective study of invasive breast cancer were categorized into patterns that have been considered to reflect immunologic function. An attempt was made to correlate these with 31 other histological and 8 clinical features, including short-term treatment failure (3 months to 4 years, average 24 months). No significant relationship to the latter was encountered. However, a lymphocyte predominance pattern was significantly associated with a stellate tumor border, absent cell reaction within the dominant tumor, absent sinus histocytosis of lymph nodes, combination tumor types, and a patient age of 55 years or more. A similar relationship between age of patient and sinus histiocytosis was found with the germinal center predominance pattern. In addition, this histologic appearance was associated with circumscribed tumors, severe cell reaction, and the infiltrating ductal carcinoma NOS and medullary types. Nodes with an unstimulated appearance were also found to be related to an absent cell reaction but marked sinus histiocytosis and a patient age of 45-54 years. Possible reasons for the differences between these findings and those of others relating prognostic value to such assessment of nodal histology is discussed, as are the findings of studies relevant to the identity of immunologic function with the morphologic appearance of nodal structure. The findings from this study fail to indicate any value of such nodal assessments as prognostic discriminants for breast cancer. Although longer periods of observation might alter this conclusion, such an event is regarded as unlikely.

Entities:  

Mesh:

Year:  1976        PMID: 174420     DOI: 10.1093/ajcp/65.1.21

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Immunological characterization of mononuclear cells and morphological findings in patients with mammary carcinoma.

Authors:  W Heidenreich; K Jagla; J Schüssler; P Börner; F Dehnhard; J Deinhardt; J Kalden; H H Peter; H Deicher
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

Review 2.  Medullary cancer of the breast revisited.

Authors:  E R Fisher; J P Kenny; R Sass; N V Dimitrov; R H Siderits; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

3.  Nucleolar organiser regions: new prognostic variable in breast carcinomas.

Authors:  E Sivridis; B Sims
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

4.  Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX.

Authors:  E R Fisher; A S Palekar; R Sass; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  Correlation of primary breast cancer histopathology and estrogen receptor content.

Authors:  E R Fisher; C K Osborne; W L McGuire; C Redmond; W A Knight; B Fisher; G Bannayan; A Walder; E J Gregory; A Jacobsen; D M Queen; D E Bennett; H C Ford
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  Axillary lymph node morphology in women with in situ breast carcinoma. An autopsy study.

Authors:  M Nielsen; L Christensen; J Jensen; J L Thomsen; J A Andersen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

7.  A rare case of invasive micropapillary carcinoma of the breast.

Authors:  Georgios-Ioannis Verras; Francesk Mulita; Levan Tchabashvili; Ioanna-Maria Grypari; Sofia Sourouni; Evangelia Panagodimou; Maria-Ioanna Argentou
Journal:  Prz Menopauzalny       Date:  2022-02-21

Review 8.  Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis.

Authors:  Georgios-Ioannis Verras; Levan Tchabashvili; Francesk Mulita; Ioanna Maria Grypari; Sofia Sourouni; Evangelia Panagodimou; Maria-Ioanna Argentou
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.